Researchers developed a quick and affordable whole-blood assay to detect autoantibodies against type I IFNs, enabling rapid diagnostics for immune disorders. This new method has potential clinical ...
Recent Research on the Use of Beta-Glucans in CVD and Immune Health By Danielle VenHuizen, MS, RDN Today’s Dietitian Vol. 26 No. 8 P. 38 Beta-glucans, a type of soluble fiber (SF) derived from several ...
The trial is expected to commence in 2025 and is projected to last approximately two to three years. Immunological responses to the vaccine will be made available as the trial advances, providing a ...